| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-11 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |